Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/2000
06/14/2000EP1007056A1 Method for the treatment of cystic fibrosis
06/14/2000EP1007037A1 Antithrombotic agents
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP0853612B1 Alpha-hydrazino acid derivatives and method for making same
06/14/2000EP0746326A4 Oligomeric compounds having nitrogen-containing linkages
06/14/2000CN1053446C Novel thiomarinol derivatives and their prepn.
06/13/2000US6075044 Heterocyclic derivatives as inhibitors of purine salvage phosphoribosyltransferases
06/13/2000US6075041 Cyclic amides
06/13/2000US6075040 Obesity and diabetes
06/13/2000US6075034 Spiro[piperidine-4,1'-pyrrolo [3,4-C] pyrrole]derivatives
06/13/2000US6075021 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and application thereof in therapeutics
06/13/2000CA1341024C Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1, 2-diamine derivatives
06/08/2000WO2000032649A1 Method of producing derivatized polymers
06/08/2000WO2000032648A1 Method of producing a polymer network
06/08/2000WO2000032589A1 Eletriptan hydrobromide monohydrate
06/08/2000WO2000032582A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
06/08/2000WO2000032552A1 Process for the preparation of functionalized chiral cyclopentanes involving transformation of azanorbornyl derivatives
06/08/2000WO2000032196A2 Inhibitors of multidrug transporters
06/08/2000WO2000032180A2 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituted indolealkanoic acids
06/08/2000DE19958722A1 Production of aminocarbazole compounds, useful as pigment intermediates, comprises catalytic reduction of a nitrocarbazole using a nickel based catalyst pretreated with alkali and an iron compound.
06/08/2000CA2385845A1 Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids
06/08/2000CA2353557A1 Inhibitors of multidrug transporters
06/08/2000CA2353394A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
06/07/2000EP1006105A1 Benzene derivatives
06/07/2000EP1006102A2 Aniline derivative and process for producing the same
06/07/2000EP1005454A1 2-acylaminopropanamines as tachykinin receptor antagonists
06/07/2000EP1005341A1 Il-8 receptor antagonists
06/07/2000CN1255922A Phthalocyanine and use of phthalocyanine as marking agent
06/06/2000US6072059 Heat development image forming process and heptamethine cyanine compound
06/06/2000US6071970 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/06/2000US6071969 Substituted aminoguanidines and methods of use thereof
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071940 Synergistic mixtures with tebuconazole
06/06/2000US6071920 Bind to 5ht 1a receptors for treating disorders of the lower urinary tract; cns disorders; anxiolytic agents; antidepressants; hypotensive agents; sleep and eating disorders
06/06/2000US6071915 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
06/06/2000US6071908 Radiation-activated cytotoxin therapy of neoplastic disease
06/06/2000US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases
06/06/2000US6071900 Heterocyclic compounds and their use
06/06/2000US6071895 Polar-substituted hydrocarbons
06/06/2000US6071861 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
06/02/2000WO2000031074A2 Indole derivatives and their use as serotonin receptor ligands
06/02/2000WO2000030639A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
06/02/2000CA2352526A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
06/02/2000CA2351526A1 Indole derivatives and their use as serotonin receptor ligands
05/2000
05/31/2000EP1004581A2 Process for the preparation of thalidomide
05/31/2000EP1004580A2 Imides as inhibitors of TNF alpha
05/31/2000EP1004579A1 Process for the preparation of 2,3-Dihydroindoles (Indolines), certain 2,3-Dihydroindoles and their use
05/31/2000EP1004572A2 Amines as inhibitors of TNF alpha
05/31/2000EP1003903A1 Process for preparing enantiomerically enriched n-derivatised lactams
05/31/2000EP1003739A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives
05/31/2000EP1003723A1 2-acylaminopropanamines as tachykinin receptor antagonists
05/31/2000EP1003721A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003504A2 Indole derivatives and their use as mcp-1 antagonists
05/31/2000EP0862549B1 Process for preparing optically active carboxylic acids
05/31/2000DE19853558A1 Verfahren zur Herstellung von 2,3-Dihydroindolen (Indolinen), neuartige 2,3-Dihydroindole sowie deren Verwendung Process for the preparation of 2,3-dihydroindoles (indolines), novel 2,3-dihydroindoles and the use thereof
05/31/2000CN1255125A Method for producing aromatic bisimides
05/31/2000CN1255059A COX-2 selective carprofen for treating pain and inflammation in dogs
05/31/2000CN1052984C New erythromycin derivative and its preparing process and application in medicine
05/31/2000CN1052979C Carbazolone derivatives and process for preparing same
05/30/2000US6069247 Reacting an acetylenecarboxy amide and an aryl or heterocyclyl halide or a group enhancing the electrophilicity of the atom to which it is attached for displacement; using a palladium compound catalyst, a base and an acid
05/30/2000US6069156 Indole derivatives as cGMP-PDE inhibitors
05/30/2000US6069153 Indenoindoles and benzocarbazoles as estrogenic agents
05/25/2000WO2000029397A1 New piperazine and piperidine compounds
05/25/2000WO2000029384A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
05/25/2000WO2000029383A1 Crystalline forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide
05/25/2000WO2000028991A1 Remedies for polycystic ovary syndrome
05/25/2000WO2000028981A2 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor
05/25/2000DE19854147A1 Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative
05/25/2000CA2350520A1 Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide
05/25/2000CA2350420A1 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor
05/24/2000EP1001973A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
05/24/2000EP1001935A1 Indole derivatives as mcp-1 receptor antagonists
05/24/2000EP1001934A1 Indole compounds as cox-2 inhibitors
05/24/2000EP1001933A1 Caspases and apoptosis
05/24/2000EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
05/24/2000EP1001927A2 Novel polyamine analogues as therapeutic and diagnostic agents
05/24/2000CN1254333A Immunotherapeutic imides/amides
05/24/2000CN1253948A Substituted tricyclic compound
05/23/2000US6066744 Catalytically hydrogenating a 1-(substituted)benzyl-5-formylindoline
05/23/2000US6066743 Heating mixture of amine reactant and anhydride reactant in a solventless environment to a first temperature to allow the reactants to at least partially condense, then heating solid reaction mixture at a second temperature to melt mixture
05/23/2000US6066742 Intermediates for the preparation of duocarmycin SA and derivatives thereof, and process for the production of the intermediates
05/23/2000US6066663 Oxidation derivatives of indolylalkylamines and their use as drugs
05/23/2000CA2161579C Process for preparing indolic compounds from n-protected indolines
05/18/2000WO2000027969A1 Bleaching compositions
05/18/2000WO2000027966A1 Bleaching compositions
05/18/2000WO2000027845A1 Spiro-indolines as y5 receptor antagonists
05/18/2000WO2000027819A2 Antrhranilic acid amides and the use thereof as medicaments
05/18/2000WO2000027808A1 N-arylsulfonyl amino acid omega amides
05/18/2000WO2000027792A1 Novel compounds and medicinal use thereof
05/18/2000WO2000027434A1 Combinations comprising a beta-agonist and a further antidiabetic agent
05/18/2000WO2000027378A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
05/18/2000WO2000008202A3 3-methylidenyl-2-indolinone modulators of protein kinase
05/18/2000WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/18/2000WO1999058096A3 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
05/18/2000CA2350714A1 Spiro-indolines as y5 receptor antagonists
05/18/2000CA2350208A1 Antrhranilic acid amides and the use thereof as medicaments
05/18/2000CA2350062A1 Combinations comprising a beta-agonist and a further antidiabetic agent
05/18/2000CA2348946A1 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
05/18/2000CA2348763A1 Novel compounds and medicinal use thereof
1 ... 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 ... 458